Ironwood Pharmaceuticals Announces CEO Transition

Go back to Ironwood Pharmaceuticals Announces CEO Transition

Ironwood Pharma (IRWD) on Watch as Sale Potential Moves Higher - Analyst

February 9, 2021 9:59 AM EST

Gordon Haskett analyst Don Bilson said odds that Ironwood Pharma (NASDAQ: IRWD) will be sold "crept higher" after it was announced CEO Mark Mallon will be leaving the company next month.

Bilson said their guess would be the period... More